Harry L. Messmore - Concepedia

Author

Harry L. Messmore

Also Known As

H L Messmore, H Messmore, H. L. Messmore, H. Messmore, H.L. MESSMORE, H.L. Messmore, HARRY L. MESSMORE, Harry L Messmore, Harry L. Messmore, Harry Messmore

248

Publications

Citations

H-Index

100

Concepts

All Affiliations

Loyola University Medical Center Loyola University Chicago Edward Hines, Jr. VA Hospital University of Chicago

About

Harry L. Messmore is an author at Loyola University Medical Center specializing in medicine, thrombosis, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	32	1.6K
2	Health Sciences	4	4	127
3	Public Health	2	2	77
4	Engineering	1	1	62
5	Natural Sciences	1	1	15

Harry L. Messmore

Publications

Citations

H-Index

Page 1

	Year	Citations
Hemostasis and Thrombosis: Basic Principles and Clinical Practice Harry L. Messmore JAMA ThrombosisVenous ThrombosisCardiovascular DiseaseBasic PrinciplesHematology	2001	441
The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and Other Antiplatelet Agents During Operative Coronary Revascularization (Executive Summary)* Victor A. Ferraris, Suellen P. Ferraris, David J. Moliterno, The Annals of Thoracic Surgery Percutaneous Coronary InterventionThrombosisCardiothoracic SurgeryCardiovascular DiseaseCoronary Artery Disease	2005	154
Synthetic Pentasaccharides Do Not Cause Platelet Activation by Antiheparin-Platelet Factor 4 Antibodies Sarfraz Ahmad, Walter Jeske, Jeanine M. Walenga, Clinical and Applied Thrombosis/Hemostasis	1999	77
Neurotoxicity associated with systemic high-dose cytosine arabinoside. Sucha Nand, Harry L. Messmore, Roma Patel, Journal of Clinical Oncology Hematological MalignancyPeripheral NeuropathyMedicinePathologyCytosine Arabinoside	1986	74
Rivaroxaban – an oral, direct Factor Xa inhibitor – has potential for the management of patients with heparin‐induced thrombocytopenia Jeanine M. Walenga, Margaret Prechel, Walter Jeske, British Journal of Haematology	2008	73
Leukemic transformation in polycythemia vera: Analysis of risk factors Sucha Nand, Harry L. Messmore, Susan G. Fisher, American Journal of Hematology	1990	65
Risk of thromboembolism during diagnostic and interventional cardiac procedures with nonionic contrast media. Ming H. Hwang, Zhen En Piao, David K. Murdock, Radiology Blood ClotThrombosisVenous ThrombosisContrast MediaHematology	1990	63
<i>In Vitro</i> Studies of the Interaction of Heparin, Low Molecular Weight Heparin and Heparinoids with Platelets Harry L. Messmore, B Griffin, Jawed Fareed, Annals of the New York Academy of Sciences EngineeringImmunologySlight Inhibitory ActivityPlatelet PathobiologyBiomedical Engineering	1989	62
IN FOCUS: Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin Margaret Prechel, Meredith K. McDonald, Walter Jeske, Journal of Thrombosis and Haemostasis ThrombopoiesisThrombosisIn FocusBlood PlateletMedicine	2005	53
Day-Night Variations in Blood Levels of Nitric Oxide, T-TFPI, and E-Selectin Eugene L. Kanabrocki, Magdalena George, Ramón C. Hermida, Clinical and Applied Thrombosis/Hemostasis	2001	53

Page 1